1. 746PCOnsensus statement on mandatory measurements in PAncreatic cancer trials for systemic treatment of unresectable disease (COMM-PACT). (18th September 2017) Authors: van Rijssen, L.B.; ter Veer, E.; Besselink, M.G.; Mali, R.M.A.; Berlin, J.; Boeck, S.; Bonnetain, F.; Conroy, T.; Deplanque, G.; Goldstein, D.; Glimelius, B.; Neoptolemos, J.P.; Reni, M.; Scheithauer, W.; van der Meer, J.; Wilmink, J.W.; van der Poel, M.J.; Busch, O.R.; van Oijen, M.G.H.; van Laa... Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials. (July 2020) Authors: Belkouz, A.; Wilmink, J.W.; Haj Mohammad, N.; Hagendoorn, J.; de Vos-Geelen, J.; Dejong, C.H.C.; Homs, M.Y.V.; Groot Koerkamp, B.; van Gulik, T.M.; van Oijen, M.G.H.; Punt, C.J.A.; Klümpen, H. Journal: Critical reviews in oncology/hematology Issue: Volume 151(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer. (April 2017) Authors: Franken, M.D.; van Rooijen, E.M.; May, A.M.; Koffijberg, H.; van Tinteren, H.; Mol, L.; ten Tije, A.J.; Creemers, G.J.; van der Velden, A.M.T.; Tanis, B.C.; Uyl-de Groot, C.A.; Punt, C.J.A.; Koopman, M.; van Oijen, M.G.H. Journal: European journal of cancer Issue: Volume 75(2017) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The impact of a mobile application on awareness for multi-center clinical colorectal cancer trials: First results of the Dutch Colorectal Cancer Group (DCCG) Trialapp. (April 2016) Authors: Huiskens, J.; Bakker, J.-M.; Coelen, R.J.S.; Olthof, P.B.; Schijven, M.P.; van Oijen, M.G.H.; van Gulik, T.M.; Punt, C.J.A. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer. Issue 17 (November 2015) Authors: Bos, A.C.R.K.; van Erning, F.N.; van Gestel, Y.R.B.M.; Creemers, G.J.M.; Punt, C.J.A.; van Oijen, M.G.H.; Lemmens, V.E.P.P. Journal: European journal of cancer Issue: Volume 51:Issue 17(2015:Nov.) Page Start: 2553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer. (June 2017) Authors: Haj Mohammad, N.; Bernards, N.; van Putten, M.; Lemmens, V.E.P.P.; van Oijen, M.G.H.; van Laarhoven, H.W.M. Journal: European journal of cancer Issue: Volume 78(2017) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗